1Bone RC.Immunologic dissonance:A continuing evolution in our understanding of the systemic inflammatory response syndrome(SIRS) and the multiple organ dysfunction syndrome (MODS). Ann Intern Med,1996,125:680-687.
2Yan SF,Tritto I,Pinsky D,et al.Induction of interleukin 6 (IL-6) by hypoxia in vascular cells,central role of the binding site for nuclear factor-IL-6.J Bio Chem,1995,270:11463-11471.
3Bone RC,Sir Isaac Newton.Sepsis,SIRS and CARS.Crit Care Med,1996,24:1125-1128.
4Yamasawa H,Ishii Y,Kitamura S.Cytokine-induced neutrophil chemoattractant in a rat model of lipopolysaccharide-induced acute lung injury. Inflammation,1999,23:263-274.
5Minty A,Chalon P,Derocq JM,et al.Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses.Nature,1993,362:248-250.
6Kim C,Schinkel C,Fuchs D,et al.Interleukin-13 effectively down-regulates the monocyte inflammatory potential during traumatic stress.Arch Surg,1995,130:1330-1336.
7Di Santo E,Meazza C,Sironi M,et al. IL-13 inhibits TNF production but potentiates that of IL-6 in vivo and ex vivo in mice.J Immunol,1997,159:379-382.
8Muchamuel T,Menon S,Pisacane P,et al.IL-13 protects mice from lipopolysaccharide-induced lethal endotoxemia:correlation with down-modulation of TNF-alpha,IFN-gamma,and IL-12 production.J Immunol,1997,158:2898-2903.
9Kim C,Schinkel C,Fuchs D,et al.Interleukin-13 effectively down-regulates the monocyte inflammatory potential during traumatic stress.Arch Surg,1995,130:1330-1336.
